Contact
searchSearch
HMP Global
Login

October 2018

Column

Editor's Page
Increasing Access to Innovative Therapies
10/15/2018
Innovations in cancer therapy hold remarkable potential to transform treatment of the disease, but it is not enough to innovate new treatments if they are not easily accessible to patients. While the issue of access...
Innovations in cancer therapy hold remarkable potential to transform treatment of the disease, but it is not enough to innovate new treatments if they are not easily accessible to patients. While the issue of access...
...
10/15/2018
Journal of Clinical Pathways
Editorial
Get to Know the Community Oncology Alliance
10/15/2018
The Community Oncology Alliance (COA) and Journal of Clinical Pathways (JCP) have joined in collaboration to keep JCP readers informed about news and research in the community oncology field, including available...
The Community Oncology Alliance (COA) and Journal of Clinical Pathways (JCP) have joined in collaboration to keep JCP readers informed about news and research in the community oncology field, including available...
The...
10/15/2018
Journal of Clinical Pathways
Clinical Pathways GPS
Addressing High Drug Costs: Integrating Value Assessment Principles Into Clinical Pathways
10/15/2018
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor, Matthew Pakizegee, PharmD, MS
The high cost of prescription medications is a common topic of debate in oncology care and in mainstream news. Many ideas on how to reduce drug prices have been proposed and debated, but stakeholders are not close to...
The high cost of prescription medications is a common topic of debate in oncology care and in mainstream news. Many ideas on how to reduce drug prices have been proposed and debated, but stakeholders are not close to...
The...
10/15/2018
Journal of Clinical Pathways
PATIENT PERSPECTIVE
Talking About Costs of Care—Part Two: Integrating Discussions Into the Clinical Workflow
10/15/2018
In Part 1 of this 2-part column series on shared decision making, we discussed the need for health care teams to create a safe and inviting environment for patients to talk about financial concerns and questions...
In Part 1 of this 2-part column series on shared decision making, we discussed the need for health care teams to create a safe and inviting environment for patients to talk about financial concerns and questions...
In...
10/15/2018
Journal of Clinical Pathways

News

Conference Coverage
American Society of Clinical Oncology Quality Care Symposium
10/15/2018
JCP Editors
First launched in 2012, the American Society of Clinical Oncology (ASCO) Quality Care Symposium brings together a multidisciplinary faculty to educate attendees on the latest innovations and collaborations in quality...
First launched in 2012, the American Society of Clinical Oncology (ASCO) Quality Care Symposium brings together a multidisciplinary faculty to educate attendees on the latest innovations and collaborations in quality...
First...
10/15/2018
Journal of Clinical Pathways

Feature

Research Reports
Implications of Manufacturer Contracting: A Quantitative Model to Assess Biosimilar Market Feasibility
10/15/2018
Abstract: Eight years have passed since Congress enacted the Biologics Price Competition and Innovation Act (BPCIA) of 2010. Since then, 12 biosimilars have received approval from the Food and Drug Administration,...
Abstract: Eight years have passed since Congress enacted the Biologics Price Competition and Innovation Act (BPCIA) of 2010. Since then, 12 biosimilars have received approval from the Food and Drug Administration,...
...
10/15/2018
Journal of Clinical Pathways
From the Field
Evolving the Delivery of CAR T-Cell Therapies to the Outpatient Setting
10/15/2018
Abstract: The availability of adoptive cell therapies allows clinicians to genetically reprogram patients’ own immune cells to find and attack cancer cells throughout the body. Chimeric antigen receptor (CAR)...
Abstract: The availability of adoptive cell therapies allows clinicians to genetically reprogram patients’ own immune cells to find and attack cancer cells throughout the body. Chimeric antigen receptor (CAR)...
...
10/15/2018
Journal of Clinical Pathways
JCP September/October 2024 Issue

Current Issue

October 2024
Volume 10
Issue 5
Current Issue
Issue Archive

Special Reports

JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

Subscribe

Journal of Clinical Pathways Newsletter

Volume 4

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use